Standard BioTools Inc reports results for the quarter ended in June - Earnings Summary

Standard BioTools

08/08/2023 23:02

* Standard BioTools Inc  LAB.OQ  reported a quarterly
adjusted
loss of 22 cents​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of 21 cents
per share.
    * Revenue rose 47.3% to $27.67 million from a year ago;
analysts
expected $24.20 million. 
    * Standard BioTools Inc's reported EPS for the quarter was a
loss
of 22 cents​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Standard BioTools Inc shares had risen by 24.4% this
quarter and
gained 105.1% so far this year.
    * The company reported a quarterly loss of $17.04 million.
    * Wall Street's median 12-month price target for Standard
BioTools
Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 10:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.21          -0.22          Missed
                                  -0.26          
                                  -0.37